|
Dr. Gong-Hong Wei is a Professor at Fudan University, Shanghai, China. Dr. Wei graduated from his PhD study in Peking Union Medical College, Beijing, China. After postdoctoral training at the University of Helsinki, he joined University of Oulu as a faculty member and recently Fudan University as a professor, heading a functional genomics laboratory for cancer research. Dr. Wei’s laboratory focuses on the epigenetic regulation of gene expression network during cancer susceptibility, initiation and progression to metastasis, and the identification of biomarkers for cancer risk prediction and stratification. Over the past several years, Dr. Wei’s team performed systems functional interpretation of noncoding genomic variations in association with cancer discovered by genome-wide association studies and investigated cancer driver genes revealed by whole genome sequencing. Dr. Wei received a prestigious Academy of Finland Research Fellow post and title of docent (honorary title granted for lifetime) in molecular genetics in 2014, and was shortly promoted as a full professor, and recently joined Shanghai Medical College of Fudan University as a distinguished professor. Dr. Wei won the Medix Prize 2015 and 2019, and the Discovery of the Year 2014, 2016 and 2018 at Biocenter Oulu, and served as a reviewer for over 40 different journals, including Nature Genetics, Nature Communications, Genome Research, Cell Research, Theranostics, Science Bulletin and so forth.
Research Focus: To explore epigenetic regulation of gene expression network over cancer predisposition and progression using integrated omics strategy and identify potential therapeutic targets and biomarkers for cancer risk prediction, stratification, and treatment.
|